Related Experiment Video
Updated: May 23, 2026
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
[Pediatric hemato-oncology: from cellular biology to individualized targeted therapies]
Nicolas-Xavier von der Weid1, Marc Ansari
1Unité d'hémato-oncologie pédiatrique, DMCP, CHUV, 1011 Lausanne. nicolas.von-der-weid@chuv.ch
Abstract:
Progresses in pediatric oncology over the last decades have been dramatic and allow current cure rates above 80%. There are mainly due to multicentre clinical trials aiming at optimizing chemotherapy protocols as well as local therapies in a stepwise approach. Most of the new anticancer drugs currently in development are based on targeted therapies, directed to specific targets present only in or on tumor cells, like growth factor receptors, mechanisms involved in proliferation, DNA repair, apoptosis, tumor invasion or angiogenesis. Concerning bone marrow transplantation also, new strategic approaches are in advanced development. They aim at reducing treatment induced toxicity and enhancing efficacy at the same time. This short paper would like to point out these new technologies, which should be known by the general practitioner.
Insights
Pediatric cancer survival rates exceed 80% due to clinical trials and targeted therapies. New bone marrow transplant strategies reduce toxicity and improve efficacy for better outcomes.
Area of Science:
- Pediatric Oncology
- Clinical Trials
- Targeted Cancer Therapies
Context:
- Dramatic progress in pediatric oncology has led to cure rates over 80% in recent decades.
- Multicenter clinical trials have been pivotal in optimizing chemotherapy and local therapies.
- The development of novel anticancer drugs focuses on targeted therapies against specific tumor cell mechanisms.
Purpose:
- To highlight advancements in pediatric oncology, including targeted therapies and bone marrow transplantation.
- To inform general practitioners about new technologies in pediatric cancer treatment.
- To emphasize the importance of staying updated on innovative treatment strategies.
Summary:
- Current pediatric cancer treatments achieve over 80% cure rates, driven by optimized chemotherapy protocols and local therapies from clinical trials.
- Emerging anticancer drugs utilize targeted therapies focusing on specific molecular targets within tumor cells, such as growth factor receptors and apoptosis pathways.
- Innovations in bone marrow transplantation aim to simultaneously decrease treatment toxicity and increase therapeutic efficacy.
Impact:
- Improved survival rates and quality of life for pediatric cancer patients.
- Enhanced understanding and application of novel treatment modalities by healthcare professionals.
- Potential for further advancements in pediatric cancer treatment through continued research and development.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...